Corrigendum to “Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination” [Radiat. Med. Protect. (2023) 204–213]
- DOI
- 10.1016/j.radmp.2025.12.006
- Published
- 2026-04
- Container
- Radiation Medicine and Protection
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.radmp.2025.12.006,
title = {Corrigendum to “Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination” [Radiat. Med. Protect. (2023) 204–213]},
author = {Zuchao Cai and David Lim and Beidi Jia and Guochao Liu and Wenwen Ding and Zhendong Wang and Zhujun Tian and Junxuan Peng and Fengmei Zhang and Chao Dong and Zhihui Feng},
year = {2026},
journal = {Radiation Medicine and Protection},
doi = {10.1016/j.radmp.2025.12.006},
url = {https://doi.org/10.1016/j.radmp.2025.12.006}
}RIS
TY - JOUR TI - Corrigendum to “Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination” [Radiat. Med. Protect. (2023) 204–213] AU - Zuchao Cai AU - David Lim AU - Beidi Jia AU - Guochao Liu AU - Wenwen Ding AU - Zhendong Wang AU - Zhujun Tian AU - Junxuan Peng AU - Fengmei Zhang AU - Chao Dong AU - Zhihui Feng PY - 2026 JO - Radiation Medicine and Protection DO - 10.1016/j.radmp.2025.12.006 UR - https://doi.org/10.1016/j.radmp.2025.12.006 ER -
APA
Cai, Z., Lim, D., Jia, B., Liu, G., Ding, W., Wang, Z., Tian, Z., Peng, J., Zhang, F., Dong, C., & Feng, Z. (2026). Corrigendum to “Hexyl-pentynoic acid serves as a novel radiosensitizer for breast cancer by inhibiting UCHL3-dependent Rad51 deubiquitination” [Radiat. Med. Protect. (2023) 204–213]. Radiation Medicine and Protection. https://doi.org/10.1016/j.radmp.2025.12.006
Source records
- crossref · retrieved 2026-09-27T02:16:09.269Z